Literature DB >> 18417308

Traditional Chinese drug ShuXueTong facilitates angiogenesis during wound healing following traumatic brain injury.

Xiaoying Jin1, Gang Shen, Feng Gao, Xuesheng Zheng, Xiaoyan Xu, Fang Shen, Gu Li, Jiangbiao Gong, Liang Wen, Xiaofeng Yang, Xiaodong Bie.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: ShuXueTong injection is a traditional Chinese drug designed to treat the patients of "blood stasis and stagnation (yu xue yu zhi)", including subacute brain trauma. However, the mechanism of the therapeutic effect of ShuXueTong on traumatic brain injury is unknown yet. AIM OF THE STUDY: We hypothesized that ShuXueTong may promote the brain wound healing by facilitating angiogenesis. Thus this study was designed to explore this hypothesis.
MATERIALS AND METHODS: By means of microvessel count, Western blotting, immunocytochemistry, methyl thiazolyl tetrazolium assay and etc., the effect of ShuXueTong on the angiogenesis of brain wound was studied and then its influence on the VEGF/VEGFR-2 pathway were explored.
RESULTS: ShuXueTong facilitates angiogenesis in the brain wound and improves the neurological function of the traumatized rats. VEGF expression in the lesion was elevated due to ShuXueTong induction. The in vitro experiment revealed VEGFR-2 and SRF expression in the endothelial cells were enhanced when exposed to ShuXueTong for merely 1d. Moreover, ShuXueTong promoted the endothelial cell proliferation via the VEGF/VEGFR-2 pathway.
CONCLUSIONS: The mechanism of the therapeutic effect of ShuXueTong on traumatic brain injury lies at least partly in the enhanced angiogenesis in the lesion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18417308     DOI: 10.1016/j.jep.2008.02.033

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  8 in total

Review 1.  Accelerated RBC senescence as a novel pathologic mechanism of blood stasis syndrome in traditional East Asian medicine.

Authors:  Sooseong You; Bongki Park; Myeong Soo Lee
Journal:  Am J Transl Res       Date:  2015-03-15       Impact factor: 4.060

Review 2.  Evidence-based review of oral traditional Chinese medicine compound recipe administration for treating weight drop-induced experimental traumatic brain injury.

Authors:  Bo Yang; Zhe Wang; Chenxia Sheng; Yang Wang; Jing Zhou; Xin-gui Xiong; Weijun Peng
Journal:  BMC Complement Altern Med       Date:  2016-03-09       Impact factor: 3.659

3.  Progesterone increases circulating endothelial progenitor cells and induces neural regeneration after traumatic brain injury in aged rats.

Authors:  Zhanying Li; Bin Wang; Zhisheng Kan; Baoliang Zhang; Zhuo Yang; Jieli Chen; Dong Wang; Huijie Wei; Jian-ning Zhang; Rongcai Jiang
Journal:  J Neurotrauma       Date:  2011-07-27       Impact factor: 5.269

4.  Beneficial effect of the traditional chinese drug shu-xue-tong on recovery of spinal cord injury in the rat.

Authors:  Li-Yun Jia; An-Hui Yao; Fang Kuang; Yu-Kai Zhang; Xue-Feng Shen; Gong Ju
Journal:  Evid Based Complement Alternat Med       Date:  2010-09-08       Impact factor: 2.629

Review 5.  Korean studies on blood stasis: an overview.

Authors:  Bongki Park; Sooseong You; Jeeyoun Jung; Ju Ah Lee; Kyung-Jin Yun; Myeong Soo Lee
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-02       Impact factor: 2.629

6.  Shuxuetong injection simultaneously ameliorates dexamethasone-driven vascular calcification and osteoporosis.

Authors:  Zhe Xu; Xiaoguang Liu; Yanqing Li; Hongliang Gao; Tao He; Chunlei Zhang; Wei Hao; Xu Teng
Journal:  Exp Ther Med       Date:  2021-01-08       Impact factor: 2.447

7.  Effects of traditional Chinese medicine Shuxuetong injection on random skin flap survival in rats.

Authors:  Leyi Cai; Wenfang Huang; Dingsheng Lin
Journal:  ScientificWorldJournal       Date:  2014-02-26

8.  Effects of shuxuetong injection for cerebral infarction: A protocol for systematic review and meta-analysis.

Authors:  Hua Fang; Honglong Zhou; Jicai Zhang; Ziyi Li; Zhen Chen; RaoRao Yuan; Xiangqun Huang; Junyong Yang; Jianqiang Zhang; Shuo Wang; Yong Huang; Shangwei Hu
Journal:  Medicine (Baltimore)       Date:  2020-08-28       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.